BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy

Published:2022-08-30 Issue:3 Volume:44 Page:524-537
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Liu Wei,Zhu Shi-ou,Guo Yu-lin,Tu Long-fang,Zhen Yong-qi,Zhao Rong-yan,Ou-Yang Liang,Kurihara Hiroshi,He Rong-Rong,Liu Bo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-022-00972-w.pdf

Reference59 articles.

1. Tandan R, Bradley WG. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol. 1985;18:271–80.

2. van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.

3. Valdmanis PN, Rouleau GA. Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008;70:144–52.

4. Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13:96–104.

5. Tu LF, Zhang TZ, Zhou YF, Zhou QQ, Gong HB, Liang L, et al. GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS. J Adv Res. 2022; https://doi.org/10.1016/j.jare.2022.02.016.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy modulation in cancer therapy: Challenges coexist with opportunities;European Journal of Medicinal Chemistry;2024-10

2. BL-918 activates PINK1/Parkin signaling pathway to ameliorate the progression of Parkinson’s disease;Journal of Biological Chemistry;2024-08

3. Development of the ULK1-Recruiting Chimeras (ULKRECs) to enable proximity-induced and ULK1-dependent degradation of mitochondria;2024-04-15

4. Targeting autophagy drug discovery: Targets, indications and development trends;European Journal of Medicinal Chemistry;2024-03

5. Natural products targeting macroautophagy signaling in hepatocellular carcinoma therapy: Recent evidence and perspectives;Phytotherapy Research;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3